CLINICAL_TRIALS
trial_result
· 2013-07-15
Clinical Trial Update: Polycystic Ovary Syndrome and Liraglutide [Phase 4]
Summary
A Phase 4 clinical trial evaluating liraglutide for polycystic ovary syndrome and obesity has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Medical Centre Ljubljana | Conditions: PCOS, Obesity | Phase 4 | Status: COMPLETED